The Metabolism of Separase Inhibitor Sepin-1 in Human, Mouse, and Rat Liver Microsomes
Separase, a known oncogene, is widely overexpressed in numerous human tumors of breast, bone, brain, blood, and prostate. Separase is an emerging target for cancer therapy, and separase enzymatic inhibitors such as sepin-1 are currently being developed to treat separase-overexpressed tumors. Drug me...
Main Authors: | Feng Li, Nenggang Zhang, Siddharth Gorantla, Scott R. Gilbertson, Debananda Pati |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-05-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fphar.2018.00313/full |
Similar Items
-
Data set on Separase Inhibitor–Sepin-1 toxicity on organ weights, hematology and clinical parameters in Sprague-Dawley rats
by: Nenggang Zhang, et al.
Published: (2020-04-01) -
Conservation of the separase regulatory domain
by: Michael Melesse, et al.
Published: (2018-04-01) -
Separase loss of function cooperates with the loss of p53 in the initiation and progression of T- and B-cell lymphoma, leukemia and aneuploidy in mice.
by: Malini Mukherjee, et al.
Published: (2011-01-01) -
Human liver microsomes study on the inhibitory effect of plantainoside D on the activity of cytochrome P450 activity
by: Jin Zhou, et al.
Published: (2022-07-01) -
Correction: Characterization of the Interaction between the Cohesin Subunits Rad21 and SA1/2.
by: Nenggang Zhang, et al.
Published: (2013-01-01)